63 related articles for article (PubMed ID: 1957225)
1. [Treatment of hormone-dependent neoplasms (prostatic cancer, breast cancer). The place of LH-RH analogs].
Charron M
Soins; 1991 Sep; (552):61-4. PubMed ID: 1957225
[No Abstract] [Full Text] [Related]
2. Use of analogs of LH-RH and somatostatin for the treatment of hormone dependent cancers.
Redding TW; Schally AV
Prog Clin Biol Res; 1988; 262():217-40. PubMed ID: 2897695
[No Abstract] [Full Text] [Related]
3. Potential use of analogs of luteinizing hormone-releasing hormones in the treatment of hormone-sensitive neoplasms.
Schally AV; Redding TW; Comaru-Schally AM
Cancer Treat Rep; 1984 Jan; 68(1):281-9. PubMed ID: 6362868
[TBL] [Abstract][Full Text] [Related]
4. [LHRH analogs as monthly depot preparations in treatment of advanced prostate cancer].
Urologe A; 1991 May; 30(3 Suppl):2-3. PubMed ID: 1746071
[No Abstract] [Full Text] [Related]
5. [History of clinical studies on hypothalamic hormone analogs in Mexico].
Schally AV; González Bárcena D
Gac Med Mex; 2006; 142(4):315-25. PubMed ID: 17022307
[TBL] [Abstract][Full Text] [Related]
6. [LHRH analogs--a new treatment in hormone-dependent tumors].
Wilking N; Rutqvist LE; Theve T
Lakartidningen; 1988 Feb; 85(8):620-3. PubMed ID: 3280927
[No Abstract] [Full Text] [Related]
7. [The LH-RH analogs. Drug treatment of prostate cancer].
Gerson C
Soins; 1995 Nov; (600):61-2. PubMed ID: 8715119
[No Abstract] [Full Text] [Related]
8. Growth inhibitory effect of LH-RH analogs on human breast cancer cells.
Scambia G; Panici PB; Baiocchi G; Perrone L; Gaggini C; Iacobelli S; Mancuso S
Anticancer Res; 1988; 8(1):187-90. PubMed ID: 2965864
[TBL] [Abstract][Full Text] [Related]
9. Preclinical evaluation of targeted cytotoxic luteinizing hormone-releasing hormone analogue AN-152 in androgen-sensitive and insensitive prostate cancers.
Letsch M; Schally AV; Szepeshazi K; Halmos G; Nagy A
Clin Cancer Res; 2003 Oct; 9(12):4505-13. PubMed ID: 14555524
[TBL] [Abstract][Full Text] [Related]
10. Hypothalamic hormones and cancer.
Schally AV; Comaru-Schally AM; Nagy A; Kovacs M; Szepeshazi K; Plonowski A; Varga JL; Halmos G
Front Neuroendocrinol; 2001 Oct; 22(4):248-91. PubMed ID: 11587553
[TBL] [Abstract][Full Text] [Related]
11. Complete regression of MX-1 human breast carcinoma xenografts after targeted chemotherapy with a cytotoxic analog of luteinizing hormone-releasing hormone, AN-207.
Kahán Z; Nagy A; Schally AV; Halmos G; Arencibia JM; Groot K
Cancer; 1999 Jun; 85(12):2608-15. PubMed ID: 10375109
[TBL] [Abstract][Full Text] [Related]
12. Complete androgen blockade for the treatment of prostate cancer.
Labrie F; Dupont A; Belanger A
Important Adv Oncol; 1985; ():193-217. PubMed ID: 3916740
[No Abstract] [Full Text] [Related]
13. [Gonadotropin-releasing hormone analogues in the treatment of metastatic breast carcinoma].
Nesković-Konstantinović Z; Radulović S; Vuletić L
Srp Arh Celok Lek; 1993; 121(1-2):33-5. PubMed ID: 8202820
[TBL] [Abstract][Full Text] [Related]
14. [Introduction: recent progress in therapy of prostatic carcinoma and other hormone dependent pathology with the use of agonistic analogs of LHRH].
Bertelli A
Drugs Exp Clin Res; 1990; 16 Suppl():1-2. PubMed ID: 2081448
[No Abstract] [Full Text] [Related]
15. [Treatment of prostatic cancer with slow-release formulation of luteinizing hormone releasing hormone (LH-RH) analog].
Fuse H; Akimoto S; Akakura K; Shimazaki J; Murakami S
Hinyokika Kiyo; 1988 Mar; 34(3):555-60. PubMed ID: 3133936
[TBL] [Abstract][Full Text] [Related]
16. Ovarian ablation as treatment for young women with breast cancer.
Davidson NE
J Natl Cancer Inst Monogr; 1994; (16):95-9. PubMed ID: 7528032
[TBL] [Abstract][Full Text] [Related]
17. Effective treatment of metastatic MDA-MB-435 human estrogen-independent breast carcinomas with a targeted cytotoxic analogue of luteinizing hormone-releasing hormone AN-207.
Chatzistamou L; Schally AV; Nagy A; Armatis P; Szepeshazi K; Halmos G
Clin Cancer Res; 2000 Oct; 6(10):4158-65. PubMed ID: 11051271
[TBL] [Abstract][Full Text] [Related]
18. [Pretreatment with chlormadinone acetate in prostate cancer patients treated with a luteinizing hormone-releasing hormone analogue].
Yamamoto A; Sumiyoshi Y; Miyake N; Yokozeki H; Kanayama H; Kagawa S
Hinyokika Kiyo; 1998 Aug; 44(8):557-63. PubMed ID: 9783191
[TBL] [Abstract][Full Text] [Related]
19. [New approaches to treatment of various cancers based on cytotoxic analogs of LHRH, somatostatin and bombesin].
Schally AV
An R Acad Nac Med (Madr); 2004; 121(3):493-500. PubMed ID: 15751842
[TBL] [Abstract][Full Text] [Related]
20. Hormonal treatment of advanced disease: some newer aspects.
Griffiths K; Eaton CL; Harper ME; Turkes A; Peeling WB
Semin Oncol; 1994 Oct; 21(5):672-87. PubMed ID: 7939755
[No Abstract] [Full Text] [Related]
[Next] [New Search]